Dementia and Alzheimer Disease

Epilepsy

Headache and Migraine

Movement Disorders

Multiple Sclerosis

Neuromuscular

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Peers & Perspectives

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

International Journal of MS Care

Resources

Disease Spotlight

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

eNewsletter

Print Subscription

Articles

Pitolisant, marketed as Wakix, recently received approval from the European Medicines Agency for pediatric narcolepsy with or without cataplexy.  

EMA Approves Pitolisant for Pediatric Narcolepsy

In total, 302 pharmacodynamic changes due to CT1812 were identified, with 11 Alzheimer-related priority biomarkers altered in comparison with placebo.

CT1812’s Impact on Alzheimer-Related Biomarkers Suggests Altering Disease Effect

Videos

The neuroophthalmologist at Mayo Clinic discussed the current understanding of optic neuritis in neuromyelitis optica and the ways clinicians are working to improve recovery. [WATCH TIME: 4 minutes]

Improving Detection, Recovery of Optic Neuritis in NMOSD: John Chen, MD, PhD

Despite a pause in the trial due to the COVID-19 pandemic, patients who opted to continue treatment into the open-label extension demonstrated significant improvements in Parkinson disease dementia symptoms for up to 48 weeks.

Blarcamesine Deemed Safe, Effective in Phase 2 Extension Study of Parkinson Disease Dementia

Senior vice president of research at The ALS Association. 

The senior vice president of research at The ALS Association talked about the complexities of ALS and the importance of collaboration in research at the 2023 MDA conference. [WATCH TIME: 5 minutes]  

Importance of Coordination in ALS Collaborative Research: Kuldip Dave, PhD

, has been with the team since October 2019. Follow him on Twitter 

The director of the Comprehensive Epilepsy Center at NYU Langone provided perspective on the advantages modified Atkins diets bring to patients with epilepsy and those considering epilepsy surgery.

NeuroVoices: Orrin Devinsky, MD, on Metabolic Changes and Benefits of Modified Atkins Diet in Epilepsy Surgery

The neuroophthalmologist at mayo clinic provided context on the importance of raising awareness for NMOSD and the signs that precede clinical events. [WATCH TIME: 3 minutes]

Improvements in Awareness of NMOSD, Optic Neuritis: John Chen, MD, PhD

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

Twitter

LinkedIN

Spotlight

MDA 2023

NMOSD

Narcolepsy

Parkinson Disease

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

The News Network video series features a variety of clinicians providing updates on the major data and paradigm-affecting updates from societal meetings and conferences focused on patients with neurologic diseases.

1rem

Rapid Readout: Clinical Updates in Multiple Sclerosis From CMSC 2020

The Multidisciplinary Theme of CMSC 2020

Progressive MS: The 2020 Whitaker Lecture

Ocrelizumab Compared to Glatiramer Acetate and Dimethyl Fumarate for MS

Post Hoc Analysis: Phase 3 ASCLEPIOS I and II Trials in Relapsing MS

Primary Results From the ENSEMBLE PLUS Study

Post Hoc Analysis: Phase 3 EXPAND Trial in Secondary Progressive MS

Open-Label Extension: Phase 3 OPERA I and II Trials in Relapsing MS

CMSC Data Release: Abstract DXT58 and MS Risk Reduction

Open-Label Extension: BTKI in Relapsing MS Over 108 Weeks